文献速递腹部泌尿生殖MR

弥散加权MRI作为肝硬化肝脏肝细胞癌筛查工具:与移植肝标本数据的相关性——一项初步研究

Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data-a pilot study.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

单机构回顾性研究纳入37例肝硬化肝移植患者,比较单独弥散加权成像(DWI)与完整多期钆特醇增强MRI检测肝细胞癌的效能,以移植肝标本(36例)或活检(1例)为参考标准。三位独立阅片者平均结果显示DWI敏感度78%、特异度88%,完整MRI敏感度90%、特异度82%,McNemar检验示两者无显著差异(p=0.3458),DWI的阳性预测值和阴性预测值与完整多期MRI相当,可能具有筛查作用。

要点

  • DWI单独检测肝硬化肝细胞癌的敏感度78%、特异度88%,完整多期增强MRI敏感度90%、特异度82%。
  • DWI与完整多期MRI的阅片一致性简单Kappa系数为0.6716(95%CI 0.5332-0.8110),McNemar检验p=0.3458示无显著差异。
  • 运动伪影、大量腹水和技术问题会降低病灶检出。

核心结论

  • 在肝硬化患者中,DWI检测肝脏病灶的阳性预测值和阴性预测值与完整多期MRI检查相当,可能具有筛查作用。

研究设计与样本

  • 单机构回顾性研究,经IRB批准并符合HIPAA,纳入37例肝移植患者(25男12女,年龄范围21-70岁),以移植肝标本(36例)或活检(1例)为参考标准,所有MRI均在移植前六个月内完成。

关键影像表现/征象

  • DWI上识别出的病灶大小范围为1.5至5 cm。
  • 运动伪影、大量腹水和技术问题存在时,病灶检出降低。

诊断标准与关键数值

  • DWI单独检测肝脏病灶:敏感度78%(95%CI 65-89%),特异度88%(95%CI 77-95%),阳性预测值85%(95%CI 72-94%),阴性预测值83%(95%CI 71-91%)。
  • 完整多期MRI检查:敏感度90%(95%CI 76-97%),特异度82%(95%CI 66-92%),阳性预测值83%(95%CI 69-93%),阴性预测值89%(95%CI 74-97%)。

临床应用与阅片要点

  • 三位独立阅片者在不知晓MRI报告和病理报告的情况下,随机顺序在放射科PACS上分两次独立阅片:先仅判读DWI,再判读包含DWI的完整多期MRI。
  • 由两位可获取患者移植肝标本数据的放射科医师进行共识判读以定位病灶。

局限性

  • 本研究为单机构回顾性研究。
  • 本研究为初步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to compare the sensitivity and specificity of diffusion-weighted liver MRI alone with complete, multiphasic gadoteridol-enhanced MRI for the detection of hepatocellular carcinoma in cirrhotic patients before liver transplant.

MATERIALS AND METHODS: This single institution retrospective study was performed after IRB approval and was HIPAA compliant. MRI scans of 37 patients who underwent liver transplant were evaluated and findings correlated with liver explant (36) or biopsy (1). All MRI scans were obtained within six months of explant. MRI from 17 patients with liver lesions by report at imaging subsequently proven to be HCC at pathology and 20 controls without liver lesions by imaging and pathology were reviewed in random order on the radiology PACS by three independent readers blinded to the MRI reports and pathology reports in two separate sittings. First, only the diffusion-weighted images (DWI) were interpreted. Second, the complete multiphasic MRI exam with DWI was reviewed. A consensus read was obtained by two separate radiologists who had access to the patients' explant data in order to map lesions. Reader-specific and pooled classification was assessed using sensitivity, specificity, positive predictive value, and negative predictive values and corresponding 95% confidence intervals (CI) for both DWI and complete MRI examination readings compared to pathology. McNemar's test and Kappa coefficient were used to assess differences (agreement) in DWI and complete examination readings.

RESULTS: A total of 37 patients have been studied (25M 12F age range 21-70). Averaged results of the three independent readers demonstrated a sensitivity of 78% (95% CI 65-89%) and specificity of 88% (95% CI 77-95%) for DWI alone for detection of liver lesions, with a positive predictive value of 85% (95% CI 72-94%) and a negative predictive value of 83% (95% CI 71-91%). Review of the complete MRI exam showed a sensitivity of 90% (95% CI 76-97%) and a specificity of 82% (95% CI 66-92%) with a positive predictive value of 83% (95% CI 69-93%) and a negative predictive value of 89% (95% CI 74-97%). McNemar's agreement test revealed no significant difference between the DWI and complete multiphasic interpretations (p = 0.3458), with simple Kappa coefficient of 0.6716 (95% CI 0.5332-0.8110). Lesions identified on DWI ranged in size from 1.5 to 5 cm. Detection of lesions was decreased in the presence of artifact from motion, large ascites, and technical issues.

CONCLUSION: Diffusion-weighted MRI has NPV and PPV comparable to complete multiphasic MRI examination for liver lesion detection in cirrhotic patients and may have a role in screening.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. McNamara MM, Thomas JV, Alexander LF, et al. Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data-a pilot study. Abdom Radiol (NY). 2018. PMID: 29500648. doi:10.1007/s00261-018-1535-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。